Sanofi (SNY) Change in Cash (2009 - 2026)

Sanofi has disclosed Change in Cash across 18 years of filings, most recently posting $929.9 million for Q2 2026.

• In Q2 2026, Change in Cash fell 88.85% year-over-year to $929.9 million; the TTM figure through Jun 2026 stood at -$5.9 billion (down 142.58% YoY), while the FY2025 annual figure was $251.4 million, up 118.31% from the prior year.
• Change in Cash came in at $929.9 million for Q2 2026 at Sanofi, up from -$2.5 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $10.6 billion in Q3 2023 to a low of -$6.8 billion in Q2 2023.
• Average Change in Cash over 5 years is $572.8 million, with a median of $578.5 million recorded in 2025.
• Year-over-year, Change in Cash jumped 424.59% in 2025 and tumbled 527.59% in 2026.
• Over 5 years, Change in Cash stood at $6.1 billion in 2022, then slumped by 171.51% to -$4.3 billion in 2023, then jumped by 68.7% to -$1.4 billion in 2024, then tumbled by 349.46% to -$6.1 billion in 2025, then surged by 115.26% to $929.9 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $929.9 million in Q2 2026, -$2.5 billion in Q1 2026, and -$6.1 billion in Q4 2025.